Title:SSRI Exposure During Pregnancy – The Risks to Newborns

Join us for an in-depth discussion on the potential risks of SSRI (Selective Serotonin Reuptake Inhibitor) exposure during pregnancy. Hosted by Amy Racines, R&D Projects Coordinator at USDTL, this session will explore key topics related to SSRIs, including their history, their impact on the brain, and the potential risks they pose to newborns when used during pregnancy. The presentation will also address the effects of untreated depression during pregnancy on both the pregnant individual and the baby.

In addition, we will highlight the crucial role of newborn testing to gather consistent data for better understanding long-term outcomes. This webinar will offer valuable insights for healthcare professionals, researchers, and anyone interested in the intersection of maternal mental health and newborn well-being.

Key Takeaways:

• History and function of SSRIs in the brain
• Risks to newborns associated with SSRI use during pregnancy
• Impacts of depression during pregnancy on both mother and baby
• The significance of testing newborns for consistent data and long-term resources

A recording of the presentation and a certificate of attendance will be available 24-48 hours after completion. You must be subscribed to our mailing list to receive a certificate.

Click Here to Sign Up

---

Special Event: Hosted by Recovery Trek

Title: Strategies for Effective Hair & Nail Drug Testing

Did you miss the incredible WISE Webinar hosted by Recovery Trek? Don’t worry—we’ve got you covered!

What Happened? Dr. Joseph Jones, Ph.D, NRCC-TC, of USDTL, and Dr. Donna Smith shared expert insights and tackled tough cases in this engaging and informative session. 

Click to Watch Recording